A Delaware federal jury said on Friday that Revance Therapeutics owes AbbVie's Allergan Inc $56 million after finding that ...

A federal jury in Delaware found that Revance's rival product infringed patents for Allergan's market-leading neurotoxin ...

A federal jury July 18 said Revance Therapeutics' skin medication infringed on patents for anti-wrinkle treatment Botox and owes AbbVie-owned Allergan $56 million.

A MUM was terrified her boob job would kill her after it led to a rare disease. Colette Cooper went under the knife in 2014 ...

Bishop Auckland, County Durham local Colette Cooper woke up one morning to notice that one of her breasts had grown overnight ...

AbbVie and its subsidiary Allergan have had a long run of unchallenged success in the market with cosmetic and therapeutic ...

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the 2025 class of entrepreneurs who will participate in ...

In October 2024, Allergan Aesthetics scored a major FDA approval milestone when the company’s Botox Cosmetic injectable ...

A spa in Massachusetts is being investigated after 18 customers reported botulism symptoms after getting injections there.

Mum Colette Cooper has claimed that her boob job was to blame for developing cancer, after developing BIA-ALCL after getting ...

Labor’s $15b manufacturing fund and superannuation giants have piled into a VC fund backing start-ups with promising drug and ...

The global derma fillers market, valued at US$3.74 billion in 2024 stood at US$4.13 billion in 2025 and is projected to advance at a resilient CAGR of 12.1% from 2025 to 2030, culminating in a ...